These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34882157)

  • 21. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
    Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
    Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orally administered covalently-assembled antioxidative peptide nanoparticles for inflammatory bowel disease therapy.
    Ma X; Gong H; Liu Y; Liu Y; Ogino K; Xing R; Yan X
    J Colloid Interface Sci; 2022 Nov; 626():156-166. PubMed ID: 35780549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease.
    Nguyen TT; Trinh NT; Tran HN; Tran HT; Le PQ; Ngo DN; Tran-Van H; Van Vo T; Vong LB; Nagasaki Y
    J Control Release; 2021 Mar; 331():515-524. PubMed ID: 33616078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer Treatment.
    Lin T; Zhang Q; Yuan A; Wang B; Zhang F; Ding Y; Cao W; Chen W; Guo H
    Theranostics; 2020; 10(17):7683-7696. PubMed ID: 32685013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease.
    Date AA; Halpert G; Babu T; Ortiz J; Kanvinde P; Dimitrion P; Narayan J; Zierden H; Betageri K; Musmanno O; Wiegand H; Huang X; Gumber S; Hanes J; Ensign LM
    Biomaterials; 2018 Dec; 185():97-105. PubMed ID: 30236840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis.
    Lin M; Dong L; Chen Q; Xu H; Han X; Luo R; Pu X; Qi S; Nie W; Ma M; Wang Y; Gao F; Zhang J
    Front Bioeng Biotechnol; 2021; 9():702173. PubMed ID: 34513811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease.
    Shi C; Dawulieti J; Shi F; Yang C; Qin Q; Shi T; Wang L; Hu H; Sun M; Ren L; Chen F; Zhao Y; Liu F; Li M; Mu L; Liu D; Shao D; Leong KW; She J
    Sci Adv; 2022 Jan; 8(4):eabj2372. PubMed ID: 35089791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermosensitive hydrogel-functionalized gold nanorod/mesoporous MnO
    Zhang Z; Ji Y; Lin C; Tao L
    Mater Sci Eng C Mater Biol Appl; 2021 Dec; 131():112504. PubMed ID: 34857290
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Zhu X; Liu Y; Yuan G; Guo X; Cen J; Gong Y; Liu J; Gang Y
    Nanoscale; 2020 Nov; 12(43):22317-22329. PubMed ID: 33146638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial β-(1,3)-glucan prevents DSS-induced IBD by restoring the reduced population of regulatory T cells.
    Lee KH; Park M; Ji KY; Lee HY; Jang JH; Yoon IJ; Oh SS; Kim SM; Jeong YH; Yun CH; Kim MK; Lee IY; Choi HR; Ko KS; Kang HS
    Immunobiology; 2014 Oct; 219(10):802-12. PubMed ID: 25092569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A hybrid nanozymes
    Zhu X; Chen X; Huo D; Cen J; Jia Z; Liu Y; Liu J
    Biomater Sci; 2021 Jul; 9(15):5330-5343. PubMed ID: 34190241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
    Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
    Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease.
    Sinhmar GK; Shah NN; Chokshi NV; Khatri HN; Patel MM
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1078-1089. PubMed ID: 29376433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease.
    Zhang Q; Tao H; Lin Y; Hu Y; An H; Zhang D; Feng S; Hu H; Wang R; Li X; Zhang J
    Biomaterials; 2016 Oct; 105():206-221. PubMed ID: 27525680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
    Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
    ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis.
    Tang B; Zhu J; Zhang B; Wu F; Wang Y; Weng Q; Fang S; Zheng L; Yang Y; Qiu R; Chen M; Xu M; Zhao Z; Ji J
    Front Immunol; 2020; 11():592084. PubMed ID: 33240279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.
    Sann H; Erichsen Jv; Hessmann M; Pahl A; Hoffmeyer A
    Life Sci; 2013 Apr; 92(12):708-18. PubMed ID: 23399699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticles Derived from the Natural Antioxidant Rosmarinic Acid Ameliorate Acute Inflammatory Bowel Disease.
    Chung CH; Jung W; Keum H; Kim TW; Jon S
    ACS Nano; 2020 Jun; 14(6):6887-6896. PubMed ID: 32449857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model.
    Leonard F; Ali H; Collnot EM; Crielaard BJ; Lammers T; Storm G; Lehr CM
    ALTEX; 2012; 29(3):275-85. PubMed ID: 22847255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ROS responsive polydopamine nanoparticles to relieve oxidative stress and inflammation for ameliorating acute inflammatory bowel.
    Yan M; Zhu L; Wu S; Cao Y; Mou N; Chi Q; Wang G; Zhong Y; Wu W
    Biomater Adv; 2022 Nov; 142():213126. PubMed ID: 36191534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.